RESEARCH LANDSCAPE OF REPURPOSED MEDICATIONS IN CANCER TREATMENT: A MULTI-DATABASE BIBLIOMETRIC ANALYSIS OF ELEVEN OFF-PATENT THERAPEUTICS
Background: Drug repurposing offers potential advantages for cancer therapy development, particularly when utilizing medications with established safety profiles and expired patents. While individual repurposed medications have been investigated for oncological applications, comprehensive comparative analyses of research distribution patterns across multiple therapeutic candidates appear limited in the literature. Understanding these patterns may provide insights into research priorities and potential knowledge gaps. Aim: This exploratory study was designed to quantify and compare the volume of scientific literature examining the anticancer potential of eleven selected off-patent medications across different pharmacological classes. Methods: Bibliometric searches were conducted across five databases (Google Scholar, BVS, PubMed, NIH, and Science.gov) using standardized search terms combining each medication name with "cancer" and "cancer treatment." The selected medications included ivermectin, fenbendazole, mebendazole, albendazole, metformin, propranolol, disulfiram, valproic acid, thalidomide, dexamethasone, and hydroxychloroquine. Basic statistical analyses were performed to examine the distribution patterns and correlations within the database. Results: The search yielded 3,226,066 total publications with considerable variation in distribution patterns. Dexamethasone accounted for the largest proportion (1,538,058 publications, 47.68%), followed by metformin (697,172 publications, 21.61%). Some medications with smaller overall publication volumes demonstrated higher proportions of treatment-specific research, such as fenbendazole (87.82%), disulfiram with copper (86.54%), and hydroxychloroquine with zinc (75.21%). The Herfindahl Index indicated a high concentration of research attention (0.2870). Discussion: The findings suggest substantial variation in research attention across the selected medications. While some medications dominate the literature, others with focused treatment-specific research may warrant further investigation. The inverse relationship observed between total publication volume and treatment specificity suggests that research patterns in this field may be more complex than absolute publication counts indicate. Conclusions: This preliminary bibliometric assessment reveals an uneven distribution of research attention among repurposed medications being investigated for cancer applications. These patterns may inform future research prioritization, though further qualitative analysis would be valuable to assess the clinical significance of these quantitative observations.
Read ArticleENTREPRENEURSHIP, INNOVATION, AND COMPETENCY-BASED EDUCATION - INTERVIEW WITH PROF. PAULO CÂMARA. ENGLISH VERSION
Background: The interview was conducted with Professor Paulo Wilton da Luz Câmara, who serves as an associate professor at the University of Vassouras, general coordinator of postgraduate lato sensu programs, and deputy coordinator of the Master's in Environmental Sciences. The Professor has extensive academic and corporate experience. Objectives: The main objectives were to understand the importance of corporate experience in the role of a professor and researcher, discuss the evolution of public entrepreneurship policies in Brazil, understand the role of incubators, explore research on renewable energies in the defense sector, and learn about planned innovations for postgraduate programs. Methods: The interview was conducted in a semi-structured format with open-ended questions. The audio was transcribed for subsequent analysis and content structuring. Results: Corporate experience significantly influences academic performance. There has been relative improvement in public entrepreneurship policies, but the involved bodies lack specific knowledge. Incubators are necessary tools to foster entrepreneurship and innovation. The main challenges in renewable energy research for defense are awareness and organizational policy. Planned innovations for postgraduate programs include connecting education levels, shared management, and an open committee. Discussion: The Professor highlights the importance of practical corporate experience in enriching academic performance, noting advances in entrepreneurship policies while emphasizing the need for more specific knowledge. Incubators are seen as essential to fostering entrepreneurship and innovation. In the field of renewable energy applied to defense, challenges are related to awareness and organizational policy. Conclusion: The interview underscores the relevance of practical corporate experience in enriching academic performance and the need to improve entrepreneurship policies. Incubators are fundamental to fostering entrepreneurship and innovation. Research on renewable energies in defense faces challenges of awareness and organizational policy. Planned innovations for postgraduate programs aim for greater integration and participation.
Read ArticleE-SELECTIN AS A BIOMARKER IN FEMALE PATIENTS WITH Β-THALASSEMIA IN AL- NAJAF PROVENCE, IRAQ
E-selectin, as identified (CD62E), is expressed on endothelial cells after stimulation with inflammation cytokines. β-Thalassemia diseases (βT) and early diagnosis are of utmost significance in the entire world population. This study was performed in the Thalassemia Center of the Al-Zahraa Educational Hospital in Al-Najaf Province, Iraq, on sixty-nine with β-thalassemia (54 βT major and 15 βT Intermedia) aged 8-40 years who transfused blood. Compared to 20 healthy volunteers as a control group. In both βT patients and healthy groups were assessed serum E-selectin levels. It was investigated the relationship with RBC, Hb, PCV, WBC, PLT, BMI, splenic status, iron, and ferritin levels. The results revealed a significant (P<0.05) decreased values of HB, RBC, P.C.V, and BMI. In contrast, values of WBC, PLT, Iron, and Ferritin were significantly increased in βT patients as compared to the healthy control groups. A significant (P<0.05) increase in serum E- Selectin level in βT patients (20.55±0.47) ng/ml to compare with the healthy group (9.16±0.50) ng/ml. Furthermore, it was a significant decrease in groups of βT major (19.87±0.42) ng/ml more than in βT intermedia (23±1.42) ng/ml. E-Selectin revealed a significant increase (P<0.05) in progress age and associated with splenectomies and underweight groups compared to splenectomies and the normal weight groups, respectively. Also, E-Selectin levels significantly positively correlated with WBC, PLT value, iron, and Ferritin levels. However, it was no significant with RBC, PCV, Hb. As a conclusion from this study, E- Selectin is an important biomarker in β-thalassemia patients can be identified as the complications associated with iron overload, inflammatory process, and endothelial dysfunction in βT disease.
Read Article